Market Overview

UPDATE: Canaccord Genuity Lowers PT on Ameresco After Heavy Exposure to Federal Customers

Related AMRC
Mid-Morning Market Update: Markets Edge Higher; CVS Health Earnings Top Estimates
Mid-Morning Market Update: Markets Open Lower; General Electric Profit Beats Expectations

Conaccord Genuity analyst John Quealy published a report on Ameresco (NYSE: AMRC) that lowered it's price target from $12 to $10.50 and maintained a Buy rating due to heavy exposure to Federal customers.

In the report, Canaccord said, "Market disruption looks to persist in the mid-term (sequester impact), while longer-term trends stay firmly positive (growing backlog, record pipeline). 2013 revenue/net income guidance is set conservatively at $620-670M/$18-22M, factoring continued backlog conversion delays (with improvement starting later in '13)."

Ameresco closed Monday at $7.55

Latest Ratings for AMRC

Nov 2017OppenheimerMaintainsOutperform
Aug 2017Canaccord GenuityMaintainsBuy
May 2017Roth CapitalUpgradesNeutralBuy

View More Analyst Ratings for AMRC
View the Latest Analyst Ratings

Posted-In: Canaccord GenuityAnalyst Color Price Target Analyst Ratings


Related Articles (AMRC)

View Comments and Join the Discussion!